A New Destination for Oncology Education
September 15, 2025 | PIONEER, medical education, precision oncology
Medscape Oncology is pleased to announce the launch of a groundbreaking new learning space designed to provide education across tumor types and oncology disciplines: PIONEER – PrecIsion Oncology: Navigating EvidEnce for Real-world impact. This dedicated platform offers comprehensive, structured CME, organizing content by therapeutic target and tumor type to reflect the latest clinical and therapeutic advances. The result is a sharper focus on the science driving treatment decisions, ensuring physicians have the tools to deliver truly personalized care.
“This new learning center is all about providing clinicians with a one-stop destination for structured, consolidated CME, and helping them stay at the forefront of precision oncology to connect more patients with life-changing care. This is a vital resource for clinicians across oncology, and one we’re very proud to provide.” said Zhizhi Fiske, PhD, Director of Clinical Strategy at Medscape Education.
Surveys of Medscape physicians have found that 97% of physicians use biomarker or molecular target information when making treatment decisions. However, 85% of physicians frequently or occasionally encounter challenges in identifying appropriate therapies for patients with actionable mutations. Furthermore, 90% of physicians agree that a cross-tumor, target-based educational program would enhance their clinical decision-making.
“We surveyed over 100 physicians in the U.S. and E.U. The message was clear: doctors are eager to use biomarkers to guide treatment but struggle to keep up with rapid developments. Our findings confirm that while most find existing CME helpful, there is strong demand for interactive biomarker modules, expert panel discussions, and cross-tumor, target-based programs. A recurring theme was the desire for all these resources in one easily accessible place.” said Nabil Dorkhom, MD, Director Clinical Strategy at Medscape Education.
PIONEER is led by a distinguished steering committee of physician experts, including committee chair Fabrice André, MD, PhD, Head of Research, Professor of Oncology, Gustave Roussy, Villejuif, France; Benedikt Westphalen, MD, PhD, Chair, Center for Personalised Medicine,University Hospital, University of Munich, Munich, Germany; Vivek Subbiah, MD, Chief, Early-Phase Drug Development Sarah Cannon Research Institute,Nashville, Tennessee, United States; and Mary Beth Beasley, MD, Professor of Pathology, Head, Thoracic Pathology, Icahn School of Medicine at Mt. Sinai Medical Center, New York, United States.
“Precision oncology is revolutionizing cancer treatment, shifting from broad-spectrum therapies to precisely targeted interventions based on each patient’s unique molecular profile. For healthcare professionals, effective education and readily accessible, centralized information are paramount. This empowers them to harness cutting-edge diagnostics and apply optimized, individualized therapeutic strategies, ultimately improving patient outcomes,” commented committee chair Dr Fabrice André.
Physicians can start learning on the PIONEER microsite here.
Follow us on LinkedIn to stay up to date with the latest news and perspectives
About Medscape Education
Medscape Education is the leading online platform for continuing medical education (CME) and continuing education (CE), trusted by millions of healthcare professionals worldwide. With more than 30 speciality-specific learning destinations, it offers thousands of free, accredited courses for physicians, nurses, pharmacists, and other healthcare professionals. Medscape Education delivers high-impact, evidence-based education designed to support clinical decision-making, improve patient outcomes, and keep healthcare professionals current in a rapidly evolving medical landscape.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Contagious Conversations: Exploring Infectious Disease in the Digital Age
As the world of medicine continues to evolve, it's crucial to stay ahead of the curve. In this dynamic era, digital communications have emerged as a driving force in discussions...
Presenting Outstanding Outcomes from HCP Education in Multiple Myeloma at IMS in Athens
From September 27-30, members of the Medscape Education Global team were in Athens, Greece sharing 5 posters at the International Myeloma Society Annual Meeting, 2023.The posters presented the outcomes and...
Impacting Lives with Rare Disease Education
Education on rare diseases is crucial. Estimates suggest there are approximately 10,000 rare diseases, with 263–446 million people affected worldwide.Since its launch in September 2022, the Medscape Pathways in Rare...
Medscape’s Virtual Patient Simulation Makes a Significant Impact on Real-World Treatment Selection for T2D
An analysis of data using Real-World Outcomes showed that a virtual patient simulation had a significant effect on real-world treatment selection for T2D. The paper, published in JMIR Medical Education,...
A Rare Disease Update from Medscape Education
A Novel Provider Education Module to Enhance Detection of Alpha-1 Antitrypsin Deficiency
New Outcomes Are a Breath of Fresh Air at ERS
ERS 2023 will mark the new release of outcomes data by Medscape Education Global. During the poster hall sessions on September 12, the Medscape team will present a poster that...
Medscape Education Launches 20th Older Driver Safety Educational Program
Education Supported by the National Highway Traffic Safety Administration
Protecting the Heart Through Education at ESC 2023
Medscape Education Global is joining cardiology professionals from across Europe for ESC 2023 in Amsterdam. This year’s congress theme is “Joining Forces to Protect the Heart,” and Medscape will be...
Medscape’s Rare Disease Learning Center Has Reached 1 Million Learners
The Pathways in Rare Disease Learning Center celebrates a momentous achievement - engaging one million learners in its educational initiatives. This milestone signifies a profound impact on clinician confidence in...
Continuing Medical Education Outcomes are Much More Than Statistical Significance
At Medscape Education, we hold ourselves to the highest standards when it comes to analysing our programs. Our approach is unparalleled, employing a precise paired method that ensures we measure the...